MannKind Corporation to Present at Upcoming Conferences

November 3, 2009 |

1 min read

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences.

Events

MORE ON THIS TOPIC

Scenic view of downtown San Francisco California USA

Business

JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals

January 14, 2026

·

4 min read

·

Tristan Manalac

This 3D render features human icons arranged side by side and in a line. Among them, one icon at the front shines brightly, symbolizing leadership and innovation. The visual presents a powerful metaphor for leadership, innovation, and making a difference, making it ideal for themes related to leadership and inspiration in the business world.

obesity

JPM26: Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos

January 13, 2026

·

3 min read

·

Annalee Armstrong

South San Francisco, CA, USA - May 1, 2022: Exterior view of the Merck Researches Laboratories in South San Francisco, California. Merck & Co., Inc. is a global pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme (MSD) outside the United States and Canada.

Events

JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity

January 13, 2026

·

1 min read

·

Heather McKenzie

the skyline of san francisco at night

Events

JPM26 Day 1: Obesity Front-and-Center, Q4 Sales Beats

January 13, 2026

·

3 min read

·

Tristan Manalac